On 26 February, Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA), announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion for the use of VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) without ribavirin (RBV) in chronic hepatitis C virus (HCV) infected genotype 1b (GT1b) patients with compensated cirrhosis (Child-Pugh A).
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) belongs to Healthcare sector. Its net profit margin is 48.00% and weekly performance is 4.35%. On last trading day company shares ended up at $29.49.
Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN) announced it has entered into a definitive agreement with a single healthcare dedicated institutional investor to purchase approximately 15.6 million shares of its common stock and warrants exercisable for up to approximately 11.7 million shares of its common stock for gross proceeds of $5 million. The shares and warrants are being sold in units, each consisting of one share of common stock and a warrant to purchase 0.75 of a share of common stock, at an offering price of $0.32 per unit.
Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) shares remains unchanged in last trading session and ended the day at $0.37. RNN return on assets is -47.90%. Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) quarterly performance is -19.46%.
On 03 March, Ally Financial Inc. (NYSE:ALLY) shares advanced 2.48% and was closed at $18.56. ALLY EPS growth in last 5 year was 11.40%. Ally Financial Inc. (NYSE:ALLY) year to date (YTD) performance is -0.43%.
On 22 February, The Bancorp, Inc. (NASDAQ:TBBK), announces the release of its next Finetics™ Studio interview series: “The Shift from Traditional Banking” featuring Ben Katz, CEO and Founder, Card.com; Ryan Caldwell, Founder and CEO, MX; Hamed Shahbazi, CEO, TIO Networks; Lars Sandtorv, CEO, MeaWallet; and Pete Chiccino, Executive Vice President and Chief Information Officer, The Bancorp.
The Bancorp Inc. (NASDAQ:TBBK) ended the last trading day at $5.20. Company weekly volatility is calculated as 5.15% and price to cash ratio as 0.17. The Bancorp Inc. (NASDAQ:TBBK) showed a weekly performance of 13.54%.
Southcross Energy Partners, LP (NYSE:SXE) was notified on February 18, 2016 by the New York Stock Exchange (“NYSE”) that the Partnership does not presently satisfy the NYSE’s continued listing standard requiring the average closing price of the Partnership’s common units to be at least $1.00 per common unit over any period of 30 consecutive trading days. As of February 18, 2016, the average closing price of the Partnership’s common units over the preceding 30 trading-day period was $0.83 per unit.
Southcross Energy Partners, L.P. (NYSE:SXE) shares advanced 28.72% in last trading session and ended the day at $0.79. SXE Gross Margin is 22.60% and its return on assets is -3.50%. Southcross Energy Partners, L.P. (NYSE:SXE) quarterly performance is -81.52%.